Your shopping cart is currently empty

Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $123 | - | In Stock | |
| 5 mg | $297 | - | In Stock | |
| 10 mg | $519 | - | In Stock | |
| 25 mg | $832 | - | In Stock |
| Description | Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis. |
| Targets&IC50 | CFTR:255 nM (EC50) |
| In vivo | In pharmacokinetic studies, male Sprague‑Dawley rats exhibited favorable pharmacokinetic profiles following a single oral dose of 10 mg/kg Ivacaftor-D9. Plasma drug concentrations were monitored for 72 hours, with the main parameters as follows: Cmax 1970 ng/mL (CV 15%), AUC₀₋₂₄h 24260 h·ng/mL (CV 17%), C₂₄h 413 ng/mL (CV 19%), and t₁/₂ 13.9 h. In male beagle dogs, following a single oral dose of 3 mg/kg Ivacaftor-D9, the corresponding pharmacokinetic parameters were: Cmax 3643 ng/mL (CV 9%), AUC₀₋₂₄h 49782 h·ng/mL (CV 31%), C₂₄h 1418 ng/mL (CV 31%), and t₁/₂ 22.8 h. |
| Synonyms | VX-770-d9, deutivacaftor, CTP-656 |
| Molecular Weight | 401.55 |
| Formula | C24H19D9N2O3 |
| Cas No. | 1413431-07-8 |
| Smiles | C(C)(C)(C)C1=C(NC(=O)C=2C(=O)C=3C(NC2)=CC=CC3)C=C(O)C(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=C1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (99.61 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.